Thermo Fisher Scientific (TMO) Stock: Buy, Sell, or Hold?
TMO - Thermo Fisher Scientific, Inc.
$658.76
7.31 (1.12%)
▲
5d:
+7.36%
30d:
+4.97%
90d:
+41.97%
WAIT
LOW Confidence
Analysis Updated: Sep 21, 2026 12:00 AM ET
Earnings: Oct 28, 2026
Get Alerted When TMO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: TMO shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: TMO shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$770.29
Based on 6.8% avg growth
INTRINSIC VALUE TODAY
$478.29
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.2x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TMO is currently trading at $658.76, which is considered extended relative to its 30-day fair value range of $599.18 to $639.68. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.9) compared to its historical average (20.2). At these levels, the market is pricing in 5.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is approaching resistance at $663.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TMO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, TMO is in a strong uptrend. The price is approaching resistance at $663.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: TMO scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$599.18 -
$639.68
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
22.9%
Protect Your Profits
Holding TMO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($645.15)
- NEUTRAL: Trading at premium valuation - market expects 5.9% growth which is achievable
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$599.18 -
$639.68
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$594.82
Resistance Level
$663.57
Current Trend
Strong Uptrend
Technical data as of
Sep 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.93
Wall Street Target
$645.15
(-2.1%)
Revenue Growth (YoY)
10.5%
Earnings Growth (YoY)
9.4%
Profit Margin
15.0%
Valuation Premium vs History
+5.9% premium
PE vs Historical
23.9 vs 20.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+5.9%
(market-implied from PE analysis)
1-Year Target
$697.63
(+6%)
2-Year Target
$738.79
(+12%)
3-Year Target
$782.38
(+19%)
3-Yr Target (if PE normalizes)
(PE: 24→20)
PE COMPRESSION
$660.49
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.9, Growth: 9.5%)
$866.07
(+32%)
Base:
(SPY PE: 20.2, Growth: 9.5%)
$732.95
(+11%)
Bear:
(PE: 17.2, Growth: 9.5%)
$623.01
(-5%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (35x PE), but valuation improves significantly next year (24x PE) as earnings recover.
Trailing PE: 35.08 | Current EPS (TTM): $18.57
Bull Case
$1062.40
(+61%)
Analyst growth 48.3%, PE expands to 38.6
Base Case
$965.82
(+47%)
Market implied 48.3%, PE stable at 35.1
Bear Case
$442.99
(-33%)
Severe decline -20.0%, PE contracts to 29.8
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: September 21, 2026 6:33 PM ET
Data refreshes hourly during market hours. Next update: 7:33 PM
Data refreshes hourly during market hours. Next update: 7:33 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TMO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Featured in Portfolios
TMO is a key holding in these high-performance investment strategies.
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 62 BUY |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 44 HOLD |
|
LH
Laboratory Corporation o… |
STRONG BUY
20 analysts |
$343 | 57 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$344 | 36 SELL |
Advanced TMO Option Strategies
Professional options setups generated by AI based on today's TMO price and gamma walls.
